Cargo distributions differentiate pathological axonal transport impairments

Journal of Theoretical Biology

Volumn 300, Issue , 2012, Pages 277-291

  Mitchell, Cassie S ^a   Lee, Robert H ^a  

^a Emory University   (United States)

Author keywords

G93A SOD1 model; Molecular motor; Motoneuron disease; Neurofilament; Transgenic mouse

Indexed keywords

AXONEMAL DYNEIN; COPPER ZINC SUPEROXIDE DISMUTASE; KINESIN; MOLECULAR MOTOR;

EXPERIMENTAL STUDY; MOLECULAR ANALYSIS; NERVOUS SYSTEM DISORDER; NUMERICAL MODEL; TRANSPORT PROCESS;

AMYOTROPHIC LATERAL SCLEROSIS; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EXPERIMENTAL DESIGN; MATHEMATICAL MODEL; MOLECULAR PATHOLOGY; MOTOR NEURON DISEASE; MOUSE; NERVE FIBER TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN DEPLETION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONAL TRANSPORT; DISEASE MODELS, ANIMAL; HUMANS; MICE; MODELS, NEUROLOGICAL; MOLECULAR MOTOR PROTEINS; NEURODEGENERATIVE DISEASES; NEUROFILAMENT PROTEINS; PROTEIN FOLDING; SUPEROXIDE DISMUTASE;

MUS MUSCULUS;

EID: 84856997490     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2012.01.019     Document Type: Article

References (66)

1. Ackerley S., et al. Glutamate slows axonal transport of neurofilaments in transfected neurons. J. Cell Biol. 2000, 150(1):165-176.
2. Ackerley S., et al. Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J. Cell Biol. 2003, 161(3):489-495.
3. Baloh R.H., et al. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J. Neurosci. 2007, 27(2):422-430.
4. Banks J., et al. Discrete-Event System Simulation USA 2005, Pearson Education.
5. Barkus R.V., et al. Identification of an axonal kinesin-3 motor for fast anterograde vesicle transport that facilitates retrograde transport of neuropeptides. Mol. Biol. Cell 2008, 19(1):274-283.
6. Bilsland L.G., et al. Deficits in axonal transport precede ALS symptoms in vivo. Proc. Natl. Acad. Sci. U S A 2010, 107(47):20523-20528.
7. Brady S.T. A novel brain ATPase with properties expected for the fast axonal transport motor. Nature 1985, 317(6032):73-75.
8. Brown A., et al. Stochastic simulation of neurofilament transport in axons: the "stop-and-go" hypothesis. Mol. Biol. Cell 2005, 16(9):4243-4255.
9. Brownlees J., et al. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. Hum. Mol. Genet. 2002, 11(23):2837-2844.
10. Cai Q., et al. Regulation of axonal mitochondrial transport and its impact on synaptic transmission. Neurosci. Res. 2011, 70(1):9-15.
11. Craciun G., et al. A dynamical system model of neurofilament transport in axons. J. Theor. Biol. 2005, 237(3):316-322.
12. De Vos K.J., et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 2007, 16(22):2720-2728.
13. De Vos K.J., et al. Role of axonal transport in neurodegenerative diseases. Annu. Rev. Neurosci. 2008, 31:151-173.
14. Elam J.S., et al. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat. Struct. Biol. 2003, 10(6):461-467.
15. Ellis D.Z., et al. Global loss of Na,K-ATPase and its nitric oxide-mediated regulation in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2003, 23(1):43-51.
16. Erickson R.P., et al. How molecular motors are arranged on a cargo is important for vesicular transport. PLoS Comput. Biol. 2011, 7(5):e1002032.
17. Feany M.B., La Spada A.R. Polyglutamines stop traffic: axonal transport as a common target in neurodegenerative diseases. Neuron 2003, 40(1):1-2.
18. Fergani A., et al. A mutation in the dynein heavy chain gene compensates for energy deficit of mutant SOD1 mice and increases potentially neuroprotective IGF-1. Mol. Neurodegener. 2011, 6(1):26.
19. Ferreirinha F., et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J. Clin. Invest. 2004, 113(2):231-242.
20. Gao Y.Q. A simple theoretical model explains dynein's response to load. Biophys. J. 2006, 90(3):811-821.
21. Gazzola M., et al. A stochastic model for microtubule motors describes the in vivo cytoplasmic transport of human adenovirus. PLoS Comput. Biol. 2009, 5(12):e1000623.
22. Gunawardena S., Goldstein L.S. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 2001, 32(3):389-401.
23. Hart P.J. Pathogenic superoxide dismutase structure, folding, aggregation and turnover. Curr. Opin. Chem. Biol. 2006, 10(2):131-138.
24. Ittner L.M., et al. Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc. Natl. Acad. Sci U S A 2008, 105(41):15997-16002.
25. Jiang Y.M., et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 2005, 57(2):236-251.
26. Julien J.P., Mushynski W.E. Neurofilaments in health and disease. Prog. Nucleic Acid Res. Mol. Biol. 1998, 61:1-23.
27. Kam N., et al. Can molecular motors drive distance measurements in injured neurons?. PLoS Comput. Biol. 2009, 5(8):e1000477.
28. Kasher P.R., et al. Direct evidence for axonal transport defects in a novel mouse model of mutant spastin-induced hereditary spastic paraplegia (HSP) and human HSP patients. J. Neurochem. 2009, 110(1):34-44.
29. Kieran D., et al. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol. 2005, 169(4):561-567.
30. Kim J., et al. Quantitative in vivo measurement of early axonal transport deficits in a triple transgenic mouse model of Alzheimer's disease using manganese-enhanced MRI. Neuroimage 2011, 56(3):1286-1292.
31. Klumpp S., Lipowsky R. Cooperative cargo transport by several molecular motors. Proc. Natl. Acad. Sci. U S A 2005, 102(48):17284-17289.
32. Kural C., et al. Kinesin and dynein move a peroxisome in vivo: a tug-of-war or coordinated movement?. Science 2005, 308(5727):1469-1472.
33. Kuznetsov A.V. Effect of vesicle traps on traffic jam formation in fast axonal transport. Math. Biosci. 2010, 226(2):147-155.
34. LaMonte B.H., et al. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 2002, 34(5):715-727.
35. LaPointe N.E., et al. The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. J. Neurosci. Res. 2009, 87(2):440-451.
36. Lee W.C., et al. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl. Acad. Sci. U S A 2004, 101(9):3224-3229.
37. Magrane J., Manfredi G. Mitochondrial function, morphology, and axonal transport in amyotrophic lateral sclerosis. Antioxid. Redox Signal. 2009, 11(7):1615-1626.
38. Martin M., et al. Cytoplasmic dynein, the dynactin complex, and kinesin are interdependent and essential for fast axonal transport. Mol. Biol. Cell 1999, 10(11):3717-3728.
39. Miller C.C., et al. Axonal transport of neurofilaments in normal and disease states. Cell Mol. Life Sci. 2002, 59(2):323-330.
40. Misko A., et al. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J. Neurosci. 2010, 30(12):4232-4240.
41. Mitchell C.S., et al. An analysis of glutamate spillover on the N-methyl-d-aspartate receptors at the cerebellar glomerulus. J. Neural Eng. 2007, 4(3):276-282.
42. Mitchell C.S., Lee R.H. Output-based comparison of alternative kinetic schemes for the NMDA receptor within a glutamate spillover model. J. Neural Eng. 2007, 4(4):380-389.
43. Mitchell C.S., Lee R.H. Pathology dynamics predict spinal cord injury therapeutic success. J. Neurotrauma 2008, 25(12):1483-1497.
44. Mitchell C.S., Lee R.H. A quantitative examination of the role of cargo-exerted forces in axonal transport. J. Theor. Biol. 2009, 257(3):430-437.
45. Mitchell C.S., Lee R.H. Dynamic meta-analysis as a therapeutic prediction tool for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 2012, InTech.
46. Morfini G., et al. Fast axonal transport misregulation and Alzheimer's disease. Neuromolecular Med. 2002, 2(2):89-99.
47. Morfini G.A., et al. Axonal transport defects in neurodegenerative diseases. J. Neurosci. 2009, 29(41):12776-12786.
48. Morfini G.A., et al. Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin. Nat. Neurosci. 2009, 12(7):864-871.
49. Muller M.J., et al. Tug-of-war as a cooperative mechanism for bidirectional cargo transport by molecular motors. Proc. Natl. Acad. Sci. U S A 2008, 105(12):4609-4614.
50. Pantelidou M., et al. Differential expression of molecular motors in the motor cortex of sporadic ALS. Neurobiol. Dis. 2007, 26(3):577-589.
51. Saha A.R., et al. Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons. J. Cell Sci. 2004, 117(Pt 7):1017-1024.
52. Sasaki S., et al. Slow component of axonal transport is impaired in the proximal axon of transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. 2004, 107(5):452-460.
53. Sasaki S., et al. Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. 2005, 110(1):48-56.
54. Sau D., et al. Dysregulation of axonal transport and motorneuron diseases. Biol. Cell 2011, 103(2):87-107.
55. Shapiro N.P., Lee R.H. Synaptic amplification versus bistability in motoneuron dendritic processing: a top-down modeling approach. J. Neurophysiol. 2007, 97(6):3948-3960.
56. Shi P., et al. Effects of ALS-related SOD1 mutants on dynein- and KIF5-mediated retrograde and anterograde axonal transport. Biochim. Biophys. Acta 2010, 1802(9):707-716.
57. Sinadinos C., et al. Live axonal transport disruption by mutant huntingtin fragments in Drosophila motor neuron axons. Neurobiol. Dis. 2009, 34(2):389-395.
58. Strom A.L., et al. Retrograde axonal transport and motor neuron disease. J. Neurochem. 2008, 106(2):495-505.
59. Tateno M., et al. Mutant SOD1 impairs axonal transport of choline acetyltransferase and acetylcholine release by sequestering KAP3. Hum. Mol. Genet. 2009, 18(5):942-955.
60. Teuchert M., et al. A dynein mutation attenuates motor neuron degeneration in SOD1(G93A) mice. Exp. Neurol. 2006, 198(1):271-274.
61. Wang L., Brown A. Rapid intermittent movement of axonal neurofilaments observed by fluorescence photobleaching. Mol. Biol. Cell 2001, 12(10):3257-3267.
62. Wang X., et al. Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neurodegener. Dis. 2010, 7(1-3):56-59.
63. Warita H., et al. Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res. 1999, 819(1-2):120-131.
64. Williamson T.L., Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 1999, 2(1):50-56.
65. Xia C.H., et al. Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J. Cell Biol. 2003, 161(1):55-66.
66. Zhang B., et al. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol. 1997, 139(5):1307-1315.